767 / 1266
Participating countries in this study
~15 countries
~82 sites
120 evaluable patients: 3-18 years
10 patients: 6 months – 3 years
North America
•
Canada
Europe
•
Austria
•
Belgium
•
Czech
Republic
•
Denmark
•
Finland
•
France
•
Hungary
•
Italy
•
Netherlands
•
Poland
•
Spain
•
Sweden
•
UK
Asia-Pacific Region
•
Australia